Infectious and Inflammatory Diseases of the Female Genital Organs: a Course Towards Rational Antimicrobial and Antiprotozoal Therapy
https://doi.org/10.31550/1727-2378-2023-22-5-101-104
Abstract
Aim: to provide the key trends in the use of a modern combined medicinal product of ciprofloxacin and ornidazole.
Key points. The product has a combined antimicrobial and antiprotozoal effect; its pharmacological action is a result of the properties of the active ingredients — ciprofloxacin and ornidazole. The article describes the efficacy of this combination against gynaecological infections.
Conclusion. The use of the ciprofloxacin and ornidazole combination demonstrates therapeutic effect against a majority of urinogenital gynaecological conditions. The product is beneficial in case of concurrent infections, various vaginitis, pelvic inflammations and for prevention of post-surgery complications.
Keywords
ornidazole,
ciprofloxacin,
combination,
infections,
concurrent infections,
pelvic inflammations,
sexually transmitted infections
Supporting agencies: The article was written with the support of PanBio Pharm LLC
About the Authors
I. A. Apolikhina
V.I. Kulakov National Medical Scientific Centre of Obstetrics, Gynecology and Perinatal Medicine; I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
117997; 4 Academician Oparin Str.; 119991; 8 Trubetskaya Str., build. 2; Moscow
D. S. Makovskaya
V.I. Kulakov National Medical Scientific Centre of Obstetrics, Gynecology and Perinatal Medicine
Russian Federation
Russian Federation
117997; 4 Academician Oparin Str.; Moscow
References
1. Pestrikova T.Yu., Yurasov I.V., Yurasova E.A. Inflammatory disease of the womans reproductive system: modern trends in diagnosis and therapy (literature review). Gynecology. 2018;20(6):35–41. (in Russian). DOI: 10.26442/20795696.2018.6.180072
2. Buralkina N.A., Katkova A.S., Arutyunova E.E. et al. Inflammatory diseases of the pelvic organs: pathogenetic aspects, diagnosis, clinic, treatment (review). Gynecology. 2018;20(3):12–15. (in Russian). DOI: 10.26442/2079-5696_2018.3.12-15
3. Dovletkhanova E.R. Vaginal dysbiosis as a cofactor of the development of genital inflammatory diseases. Effective pharmacotherapy. Obstetrics and Gynecology. 2017;(4):20–24. (in Russian)
4. Bezhenar V.F., Molchanov O.L., Kukes I.V. et al. The effectiveness of a monopreparation containing a combination of ciprofloxacin — ornidazole in the treatment of infectious-inflammatory and dysbiotic vagina diseases. Meditsinskiy sovet. 2021;(13):207–215. (in Russian). DOI 10.21518/2079-701X-2021-13-207-215
5. Modern possibilities of antimicrobial therapy in gynecology. Èffektivnaâ farmakoterapiâ. 2022;18(7):44–46. (in Russian)
6. Dobrovolskiy A.V. Approaches to clinical development of combination medicines in the Russian Federation and the Eurasian Economic Union in view of the requirements of the current legislation. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2019;9(1):14–27 (in Russian). DOI: 10.30895/1991-2919-2019-9-1-14-27
7. Makovetskaya M. Rational therapy of urogenital mixed infections: combination of ciprofloxacin/ornidazole. Antibiotic therapy. 2013;(19):57. (in Russian)
8. Workowski K.A., Bachmann L.H., Chan P.A. et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm. Rep. 2021;70(4):1–187. DOI: 10.15585/mmwr.rr7004a1
9. Chlamydial infection: clinical guidelines of the Russian Society of Obstetricians and Gynecologists. Moscow; 2021. 34 p. (in Russian)
10. Urogenital diseases caused by Mycoplasma genitalium : clinical guidelines of the Russian Society of Obstetricians and Gynecologists. Moscow; 2021. 36 p. (in Russian)
11. Urogenital trichomoniasis : clinical guidelines of the Russian Society of Obstetricians and Gynecologists. Moscow; 2021. 47 p. (in Russian)
12. Inceboz T., Inceboz U., Ozturk S. Comparative in vitro cytotoxic effects of ornidazole, metronidazole and ciprofloxacin against Trichomonas vaginalis trophozoites. J. Chemother. 2004;16(5):459–462. DOI: 10.1179/joc.2004.16.5.459
13. Strizhakov A.N., Davydov A.I. Modern approaches to treatment of patients with non-complicated acute salpingo-oophoritis. Voprosy ginekologii, akusherstva i perinatologi. 2005;(2):30–33. (in Russian)
14. Inflammatory diseases of the female pelvic organs : clinical guidelines of the Russian Society of Obstetricians and Gynecologists. Moscow; 2021. 47 p. (in Russian)
15. Kogan B.G., Gordeeva G.D. Role of combined antibacterial agents in treatment of inflammatory diseases of the female genital organs of mixed etiology. Woman’s health. 2014;(5):86–90. (in Russian)
16. Askarova G.K., Saduov T.H., Belousova Yu.S., Mukanova K.E. The experience in application of the combined drug “Ornicip” in the treatment of urogenital chlamydiosis. Medicine. 2015;(5):78–81. (in Russian).
17. Avramenko N.V. Inflammatory pelvic organs disease in women as a leading factor of tubo-peritoneal infertility. Zaporozhye medical journal. 2014;(4):63–68. (in Russian)
Review
For citations:
Apolikhina I.A., Makovskaya D.S. Infectious and Inflammatory Diseases of the Female Genital Organs: a Course Towards Rational Antimicrobial and Antiprotozoal Therapy. Title. 2023;22(5):101-104. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-5-101-104
Views:
37
Email this article 